Detalhe da pesquisa
1.
Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
Mol Cell Biochem
; 478(7): 1599-1610, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434146
2.
Arsenic level in bladder tumor of patients from an exposed population: association with progression and prognosis.
Future Oncol
; 17(11): 1311-1323, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33648348
3.
Integrative genomics and pathway analysis identified prevalent FA-BRCA pathway alterations in arsenic-associated urinary bladder carcinoma: Chronic arsenic accumulation in cancer tissues hampers the FA-BRCA pathway.
Genomics
; 112(6): 5055-5065, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920123
4.
Divergent molecular profile of PIK3CA gene in arsenic-associated bladder carcinoma.
Mutagenesis
; 35(6): 499-508, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400797
5.
Retraction Note: Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
Mol Cell Biochem
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696002
6.
High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.
J Cancer Res Clin Oncol
; 147(8): 2309-2322, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34080067
7.
Association of arsenic with recurrence of urinary bladder cancer.
Trop Doct
; 50(4): 325-330, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515648